CROS NT acquires MDSL International
CROS NT has acquired MDSL International – a specialist clinical contract research organization focused on biometrics.
The financial terms of this deal have not been disclosed.
According to CROS NT, this acquisition is an important part of its overall group strategy as a contract research organization. The deal adds additional resources to the existing group in the UK and will provide a new headquarters for the UK company near London.
“I am delighted to expand the UK operation through this acquisition. We are adding a highly experienced team to the business and further diversifying our customer base – both important objectives of the CROS NT Group,” Andrew MacGarvey, CEO and President of CROS NT said. “We will move our UK Headquarters to Maidenhead, giving us a great location in terms of on-going recruitment and access by our customers given its proximity to London. Coming shortly after our acquisition of Stat-tech Services in the USA, this deal demonstrates our commitment to place expertise close to our customers and to grow to meet the increasing demand for our services.”
Edmund Otun, the founder of MDSL International, said, “I am pleased to have concluded the deal with CROS NT. Being part of a larger entity allows us to provide additional resources to our existing clients – something they have been asking for. CROS NT has a very strong management team, with great experience in the CRO business. I will remain with the company providing consultancy for emerging companies seeking advice on getting their products to market or securing licencing deals.”
Following the acquisition, Jo Marshall, International Managing Director for MDSL, will become the UK Country Manager for CROS NT.
“I am excited by this opportunity and looking forward to working with the CROS NT team,” Marshall said. “In addition to giving us greater critical mass here in the UK, this deal will give our existing customers access to the CROS NT technology portfolio which includes several Electronic Data Capture platforms, a Clinical Trial Management System, and electronic Patient Reported Outcomes solutions.”
Comments